Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Read More Pharma Industry News Glenmark Pharmaceuticals balances modest Q1 FY26 growth with innovation drive, global partnerships and robust pipeline ambitions Glenmark’s Q1 FY26 results reveal modest growth but highlight strong specialty launches, AbbVie licensing deal, and a robust innovation pipeline. byPallavi MadhirajuAugust 18, 2025